These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38308755)

  • 1. Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances.
    Gallo E
    Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38308755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design.
    Gallo E
    J Biomed Sci; 2024 Mar; 31(1):29. PubMed ID: 38491519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advancements in B-cell receptor sequencing fast-track the development of synthetic antibodies.
    Gallo E
    Mol Biol Rep; 2024 Jan; 51(1):134. PubMed ID: 38236361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Deep Mutational Mapping of Allosteric Protein Landscapes to Deep Learning of Allostery and Hidden Allosteric Sites: Zooming in on "Allosteric Intersection" of Biochemical and Big Data Approaches.
    Verkhivker G; Alshahrani M; Gupta G; Xiao S; Tao P
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the antibody-antigen binding interface to train image-based deep neural networks for antibody-epitope classification.
    Ripoll DR; Chaudhury S; Wallqvist A
    PLoS Comput Biol; 2021 Mar; 17(3):e1008864. PubMed ID: 33780441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field.
    Villalobos-Alva J; Ochoa-Toledo L; Villalobos-Alva MJ; Aliseda A; Pérez-Escamirosa F; Altamirano-Bustamante NF; Ochoa-Fernández F; Zamora-Solís R; Villalobos-Alva S; Revilla-Monsalve C; Kemper-Valverde N; Altamirano-Bustamante MM
    Front Bioeng Biotechnol; 2022; 10():788300. PubMed ID: 35875501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Antibody Engineering through Synthetic Evolution and Machine Learning.
    Irvine EB; Reddy ST
    J Immunol; 2024 Jan; 212(2):235-243. PubMed ID: 38166249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unleashing the Power of Artificial Intelligence in Materials Design.
    Badini S; Regondi S; Pugliese R
    Materials (Basel); 2023 Aug; 16(17):. PubMed ID: 37687620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revolutionizing enzyme engineering through artificial intelligence and machine learning.
    Singh N; Malik S; Gupta A; Srivastava KR
    Emerg Top Life Sci; 2021 May; 5(1):113-125. PubMed ID: 33835131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revolutionizing Breast Healthcare: Harnessing the Role of Artificial Intelligence.
    Singh A; Paruthy SB; Belsariya V; Chandra J N; Singh SK; Manivasagam SS; Choudhary S; Kumar MA; Khera D; Kuraria V
    Cureus; 2023 Dec; 15(12):e50203. PubMed ID: 38192969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revolutionizing Biological Science: The Synergy of Genomics in Health, Bioinformatics, Agriculture, and Artificial Intelligence.
    Biswas A; Kumari A; Gaikwad DS; Pandey DK
    OMICS; 2023 Dec; 27(12):550-569. PubMed ID: 38100404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.
    Singh S; Kumar R; Payra S; Singh SK
    Cureus; 2023 Aug; 15(8):e44359. PubMed ID: 37779744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based computational design of antibody mimetics: challenges and perspectives.
    Chaves EJF; Coêlho DF; Cruz CHB; Moreira EG; Simões JCM; Nascimento-Filho MJ; Lins RD
    FEBS Open Bio; 2024 Jun; ():. PubMed ID: 38925955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
    Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
    Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-DNA/RNA interactions: Machine intelligence tools and approaches in the era of artificial intelligence and big data.
    Cui F; Zhang Z; Cao C; Zou Q; Chen D; Su X
    Proteomics; 2022 Apr; 22(8):e2100197. PubMed ID: 35112474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big Data and Artificial Intelligence Modeling for Drug Discovery.
    Zhu H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.